New breed of VCs banking on biotech
As the era of rock-star venture capitalists investing in Internet start-ups appears to be ending, another era is dawning — one of VCs flocking into biotech and health care.
Biology Seeks a Few Good Geeks
The declaration is perhaps not as stirring as Uncle Sam calling patriotic men into the army in World War I, but Vicky Markstein is just as determined in her pursuit and convinced of its importance to the nation and the welfare of humanity.
Biotechs on edge as money evaporates
Seattle’s biotech industry is working on some of the most complicated medical science in the world, but it relies on a simple mantra its executives know by heart: “Cash is king.”
Making a Run for the Border-For Canadian Prescription Drugs
Picture a tour bus filled with American seniors heading for a visit north of the border, to Canada. Instead of paying a visit to the Canadian side of Niagara Falls, they are off to purchase Canadian prescription drugs. As strange as this sight may seem, this is part of one of the latest trends in pharmaceutical marketing: online cross-border pharmacies.
Biotech industry seeks control of its destiny
Human Genome Sciences and a small but determined group of its peers are charting unconventional territory. Their efforts to take over the production, sales and marketing of selected portions of their portfolios signals a potential turning point in the industry. The companies contend that they can and should own more of the process that delivers biotechnology’s molecules to market – a process now firmly in the control of the pharmaceutical industry.
Singapore’s biotech bid
Singapore is rolling out the red carpet to foreign scientists and entrepreneurs in an ambitious bid to build up its biotech sector. The government has set aside $2 billion for research in biotech, health care and medical technology until 2005, and pledged $285 million for science scholarships.
Big Pharma: Getting Too Big for Its Own Good?
A study by McKinsey & Co. earlier this year looked at the net present value of products out of research vs. the spending on R&D for the top pharma players over the last decade. It found no correlation between the return on investment and a company’s size
European Patent Office bars human cloning in patent
The European Patent Office added restrictions on Wednesday to a controversial patent granted in 1999 to prevent it being used to clone humans, a ruling limiting biotech research in Europe.
Woman carries human clone, group says
fringe religious movement’s South Korea-based scientific team yesterday said they had implanted a cloned human embryo in a woman, the latest of a string of similar uncomfirmed experiments to emerge from the underground field of human cloning.
Monoclonal Antibodies Look to a Bright Future
Using mAbs as therapeutics could cut preclinical development time by as much as two-thirds and cost by even greater levels.